← Insider buys
RCUS

Arcus Biosciences, Inc. · Healthcare

COO Jennifer Jarrett sold $467K of Arcus Biosciences, Inc.

Sold$466,870
$22.01Price
21,208Shares
−10%Stake

What RCUS did after the filing

Filed Dec 18Copier in Dec 19
The stock from Fri, Dec 19 open, $21.98
−4.5%
S&P 500, same days
+1.4%

Measured over 30 trading days, to the Feb 4 close.

Traded Tue, Dec 16. Filed Thu, Dec 18, 5:35 PM ET, after the close. Returns use the Dec 19 open and the Feb 4 close. Not investment advice.